Alzheimer's and Parkinson's Diseases Predict Different COVID-19 Outcomes: A UK Biobank Study.

Yu, Yizhou; Travaglio, Marco; Popovic, Rebeka; Leal, Nuno Santos; Martins, Luis Miguel

Yu, Yizhou; Travaglio, Marco; Popovic, Rebeka; Leal, Nuno Santos; Martins, Luis Miguel.

Affiliation

Yu Y; MRC Toxicology Unit, University of Cambridge, Cambridge CB2 1QR, UK.
Travaglio M; MRC Toxicology Unit, University of Cambridge, Cambridge CB2 1QR, UK.
Popovic R; MRC Toxicology Unit, University of Cambridge, Cambridge CB2 1QR, UK.
Leal NS; MRC Toxicology Unit, University of Cambridge, Cambridge CB2 1QR, UK.
Martins LM; MRC Toxicology Unit, University of Cambridge, Cambridge CB2 1QR, UK.

Geriatrics (Basel) ; 6(1)2021 Jan 26.

Article in En | MEDLINE | ID: mdl-33530357

Key words

Alzheimer's disease; COVID-19; Parkinson's disease; SARS-CoV-2

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Geriatrics (Basel) Year: 2021 Document type: Article Affiliation country: United kingdom Country of publication: Switzerland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google